Table 1.
Clinical characteristics
| Parameters | Controls | CA | RA |
|---|---|---|---|
|
Age |
14 (12–18) |
14 (13–18) |
15 (12–18) |
|
Gender (males), n |
10 |
11 |
11 |
|
FEV1 |
3.8 (2.2-5.2) |
2.8 (1.9-3.8) |
3.7 (2.1-5.1) |
|
FEV1,% |
101 (88–120) |
85.1 (62–105) |
99 (70–123) |
|
FEV1/VC |
94 (84–112) |
69.4 (50–93) |
82.5 (58–100) |
|
FEV1 reversibility |
4 (0–11) |
11 (0–45) |
3.8 (0–8) |
|
PC20 |
16 (8–32) |
0.85 (0.1-6.4) |
9.1 (0.5-30) |
|
Skin prick test |
0 (by definition) |
7 (3–14) |
3 (0–11) |
| Blood eosinophils,%* | 0.16 (0.05) | 0.25 (0.07) | 0.15 (0.04) |
Values are mean (minimum-maximum).
Median (minimum-maximum).